Newsletter
ChatGPT — The New Source for Inaccurate Drug Information
Healthcare professionals and consumers should be cautious of using ChatGPT for drug information questions | Viewpoints | By Ann Johnson, Pharm.D. and Sydney Stawarz
Newsletter
Healthcare professionals and consumers should be cautious of using ChatGPT for drug information questions | Viewpoints | By Ann Johnson, Pharm.D. and Sydney Stawarz
Newsletter
Pharmacies can bill Medicaid and commercial medical insurance plans, transforming their margins on standard services while patients access affordable, same-day care offerings.
Newsletter
In this interview with Lisa Miller, president of ASAP, she tells PTMR Publisher Bill Lockwood about the advantages of being an ASAP member. Lisa is also sr. dir. of product operations with SoftWriters
Newsletter
It’s time for the folks in Washington to stop paying lip service to the problem and pass legislation that will rein in the PBMs.
Newsletter
New infographic highlights the advantages of consolidating delivery and document management solutions with FrameworkLTC for long-term care pharmacies.
Newsletter
PrimerRx has been honored with a prestigious 2024 Silver Stevie Award® for Sales and Customer Service, as part of the annual American Business Awards competition.
Newsletter
Addressing the dual challenges of billing errors and compliance risks in addition to saving time for pharmacists, including the hidden dangers of manual billing processes. | Sponsored
Newsletter
Press Release | RedSail introduces RedSail Websites – a website solution tailored specifically for community pharmacies.
Newsletter
Press Release | McKesson Invites Community Pharmacists to Push the Industry Forward, Together
Newsletter
Cyberattack on Change Healthcare leads to ongoing efforts to restore key functionalities, address financial strain on pharmacies, maintain patient care standards, and address HIPAA concerns.
Newsletter
Empowering Pharmacy Profits Strategies for Maximizing Gains Amidst Delayed Insurance Payouts | Sponsored
Newsletter
Featured Partner | SoftWriter's Mark Fulton on decoding the decline in reimbursements amid the complex web of challenges in 2024.